Today we released our 2025 year end financial results and provided a business update.
Read the full press release on our website: www.proqr.com/press-releas...
$PRQR #Biotech #Axiomer #RNAediting
Latest posts tagged with #RNAEditing on Bluesky
Today we released our 2025 year end financial results and provided a business update.
Read the full press release on our website: www.proqr.com/press-releas...
$PRQR #Biotech #Axiomer #RNAediting
Driven by a deep curiosity about molecular biology, Seda translates emerging science into strategic direction in her role as Senior Director, Research Strategy and Innovation at ProQR.
Explore Seda’s profile and meet other members of #TeamProQR on our website: bit.ly/4b3BCXZ
#RNAEditing #Axiomer
At #TIDESAsia in Tokyo, our Chief Scientific Officer, Gerard Platenburg, shared how we are translating #Axiomer #RNAEditing into liver and CNS applications.
You can explore the presentation here:
www.proqr.com/presentation...
Xi et al. (2026) present in vivo chemogenetic RNA editing of macrophages by bioengineered viruses for sepsis treatment. This shows a new path of how to control inflammation using cell-specific gene editing and delivery. #Sepsis #RNAEditing #Immunotherapy Check out the video!
youtu.be/yPYOh3iS9WI
🧬 Could reversible RNA editing redefine heart disease care? Scientists are unlocking how this molecular switch may pave the way for precision therapies and new biomarkers. www.news-medical.net/news/2026021... #Cardiology #RNAEditing #Biotechnology @commsbio.nature.com
Carles is a Researcher at ProQR, combining a passion for biology with hands-on #RNAEditing research. Beyond the lab, he actively supports an inclusive and welcoming culture as part of the DEI team!
Meet more members of the ProQR team: bit.ly/3M09Gvm
#Axiomer #TeamProQR
If you are interested in RNA editing, ADAR1, or inositol phosphates, you may find our new preprint of interest.
“Inositol hexakisphosphate functions as a cofactor and modulator of ADAR1 activity”
Preprint available on @biorxivpreprint.bsky.social
www.biorxiv.org/content/10.6...
#ADAR1 #RNAEditing
Check out the full PR here: bit.ly/4qcxvzb
#Axiomer #RNAEditing
RNA editing fine-tunes transcriptional plasticity and enhances the adaptability of Myzus persicae to diverse host plants
Chen, Y. et al.
Paper
Details
#RNAediting #transcriptionalplasticity #Myzuspersicae
College of Medicine, National Taiwan University.
Me and members of the Huang lab.
Me and Dr. Hsien-Sung Huang.
Thank you, Dr. Hsien-Sung Huang for hosting me during my stay in #Taipei & for inviting me to present my work at #NationalTaiwanUniversity. I had a wonderful time talking #organoids, #AlternativeSplicing, #RNAediting, & Rbfox 3.
Huang lab (黃憲松實驗室) share.google/Rv5o6uwhByHV...
#Taiwan
#IonChannels
Our recent edition of the Axiomer Summit brought insightful discussions, a dynamic poster session, and exciting platform updates.
Thanks to our SAB and Board for their valuable contributions!
#RNAEditing #Axiomer #Biotech
#RNAEditing #PulmonaryArterialHypertension
ADAR1 (both p150 & p110 isoforms) ⬇️in 👤PAH (in 🫁vascular smooth muscle cell)
SMC ADAR1 KO🐭 excerbates PAH
SMC ⏫dsRNA➡️⏫PKR-eIF2B-IFNβ➡️
Macrophage M1 polarization➡️
SMC proliferation
@kekeyuan.bsky.social #CircRes 2025
www.ahajournals.org/doi/10.1161/...
Great to connect with the community at #TIDESEU in Basel last week. Gerard Platenburg, our Chief Scientific Officer, presented on translating #Axiomer RNA Editing science into targeted CNS applications.
Check out the presentation here: bit.ly/3K2y927
#RNAEditing
🔍From #IL6 in #BipolarDisorder 🧬 to #RNAediting + #AI 🤖 diagnosing #Schizophrenia—science is bridging bench to bedside 💡 @mdpiopenaccess.bsky.social #Neuroimmunology #Biomarkers www.mdpi.com/1422-0067/26...
IDT President Ajay Gannerkote explores how #AI is transforming #lifesciences—it’s converging with #genomics to accelerate #precisionmedicine, uncover new drug targets, and pioneer cutting-edge therapies like #RNAediting. Learn more in AI Journal here: https://bit.ly/3Xkh4ns
🧬 AMBER: RNA editing game-changer! Precise C-to-U conversion without DNA damage. 21% efficiency in mouse models = huge potential for genetic disease treatment 🔬 #GenomicMedicine #RNAEditing #Biotech https://emmecola.github.io/genomics-daily
The replay of our Investor and Analyst Event is now available: bit.ly/43PqFWS
Thanks to Professor Verkade for joining us! We are delighted that AX-0810 progressing to the clinic.
#Axiomer #RNAEditing $PRQR
Join us in 60 mins for our virtual Investor and Analyst Event with ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen).
Register for the event here: bit.ly/3Lb7GzE
#Axiomer #RNAEditing $PRQR
🔍From #IL6 in #BipolarDisorder 🧬 to #RNAediting + #AI 🤖 diagnosing #Schizophrenia—science is bridging bench to bedside 💡 @mdpiopenaccess.bsky.social #Neuroimmunology #Biomarkers www.mdpi.com/1422-0067/26...
Join us Nov 3 at 10:00 ET for our virtual Investor and Analyst Event with the ProQR Management and KOL Prof. Henkjan Verkade, MD, PhD (UMC Groningen).
Register for the event here: bit.ly/3Lb7GzE
#Axiomer #RNAEditing
October marks #RettSyndromeAwarenessMonth, a time to shine a light on Rett syndrome.
At ProQR, we are proud to partner with the Rett Syndrome Research Trust developing #Axiomer #RNAEditing oligonucleotides to target genetic variants that cause Rett syndrome.
We’re excited to share that our CTA for the Phase 1 study of AX-0810 in healthy volunteers has been authorized!
Join our virtual Investor and Analyst Event Nov 3, 10:00 ET.
For more details, check out the PR: bit.ly/3LjRCLX
#Axiomer #RNAEditing
David, Senior Scientist at ProQR, plays a key role in advancing cell biology research while also contributing to team leadership and workplace culture.
Meet the rest of our team at: bit.ly/4nbVZWR
#Axiomer #RNAEditing #TeamProQR
🚨 New paper alert! 🚨
Our paper entitled: "Synergy between RNA editing and alternative splicing modulates the biological properties of the voltage-gated calcium channel CaV1.3" is out now on Journal of Biological Chemistry!
www.jbc.org/article/S002...
#AlternativeSplicing #RNAediting
🧵 👇
In-depth analysis of the RNA editing landscape in intracranial aneurysms and its potential role in alternative splicing. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.09.021
🔗 In-depth analysis of the RNA editing landscape in intracranial aneurysms and its potential role in alternative splicing. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.cs...
📚 CSBJ: www.csbj.org
#RNAediting #Neuroscience #Genomics #PrecisionMedicine #BrainHealth
Genetic editing holds promise to treat incurable diseases, but #CRISPR sometimes does more harm than good. @UCSanDiego.bsky.social and @Yale.edu researchers report a new, potentially safer method: small nuclear #RNAediting.
Adenosine-to-inosine editing of miR-200b-3p is associated with the progression of high-grade serous ovarian cancer
👉 buff.ly/FMrZvtO
#HGSOC #miR200 #RNAediting
Lemelinda pairs her passion for RNA biology with research, protocol development & biosafety support, while also fostering a strong community at ProQR through our Coffee & Collaboration Café.
Meet more of the ProQR team at: bit.ly/45ZFtmq
#Axiomer #RNAEditing #TeamProQR
graphic with text "Financial Filings" and sub text that reads "2025 Q2 Report"
Today we announced our Second Quarter 2025 Operating and Financial Results. Read the press release here: bit.ly/4fwEU7Y
$PRQR #RNAEditing #Axiomer
Genetic changes in an RNA-editing enzyme reduce editing of a brain receptor gene, leading to abnormal receptor function, neuronal overactivity, seizures, and developmental delay.
#RNAediting #Neurodevelopment bit.ly/3TGUN1i